- China
- /
- Medical Equipment
- /
- SHSE:688314
Kontour (Xi'an) Medical Technology Co., Ltd. (SHSE:688314) Passed Our Checks, And It's About To Pay A CN¥0.32 Dividend
It looks like Kontour (Xi'an) Medical Technology Co., Ltd. (SHSE:688314) is about to go ex-dividend in the next four days. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important as the process of settlement involves two full business days. So if you miss that date, you would not show up on the company's books on the record date. Accordingly, Kontour (Xi'an) Medical Technology investors that purchase the stock on or after the 29th of May will not receive the dividend, which will be paid on the 29th of May.
The company's next dividend payment will be CN¥0.32 per share, on the back of last year when the company paid a total of CN¥0.32 to shareholders. Looking at the last 12 months of distributions, Kontour (Xi'an) Medical Technology has a trailing yield of approximately 1.5% on its current stock price of CN¥20.91. If you buy this business for its dividend, you should have an idea of whether Kontour (Xi'an) Medical Technology's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
Check out our latest analysis for Kontour (Xi'an) Medical Technology
If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Fortunately Kontour (Xi'an) Medical Technology's payout ratio is modest, at just 34% of profit. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. It distributed 41% of its free cash flow as dividends, a comfortable payout level for most companies.
It's positive to see that Kontour (Xi'an) Medical Technology's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut.
Have Earnings And Dividends Been Growing?
Companies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. That's why it's comforting to see Kontour (Xi'an) Medical Technology's earnings have been skyrocketing, up 20% per annum for the past five years. Earnings per share have been growing very quickly, and the company is paying out a relatively low percentage of its profit and cash flow. Companies with growing earnings and low payout ratios are often the best long-term dividend stocks, as the company can both grow its earnings and increase the percentage of earnings that it pays out, essentially multiplying the dividend.
Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Kontour (Xi'an) Medical Technology's dividend payments are broadly unchanged compared to where they were two years ago.
To Sum It Up
From a dividend perspective, should investors buy or avoid Kontour (Xi'an) Medical Technology? We love that Kontour (Xi'an) Medical Technology is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. These characteristics suggest the company is reinvesting in growing its business, while the conservative payout ratio also implies a reduced risk of the dividend being cut in the future. Overall we think this is an attractive combination and worthy of further research.
So while Kontour (Xi'an) Medical Technology looks good from a dividend perspective, it's always worthwhile being up to date with the risks involved in this stock. For example - Kontour (Xi'an) Medical Technology has 1 warning sign we think you should be aware of.
Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.
Valuation is complex, but we're here to simplify it.
Discover if Kontour (Xi'an) Medical Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:688314
Kontour (Xi'an) Medical Technology
Kontour (Xi'an) Medical Technology Co., Ltd.
Excellent balance sheet with proven track record.